Huang D Q, Guo P, Lv N H, Luo L Y
Mol Biol (Mosk). 2015 Jan-Feb;49(1):46-54. doi: 10.7868/s0026898415010061.
MicroRNAs (miRNA) are small noncoding RNAs that are critical regulators of gene function. In the recent years, miRNAs have been increasingly noted for their capacity to regulate key malignant properties of tumor cells. MicroRNA-128 (miR-128) is a brain-enriched miRNA that is normally involved in the development of the nervous system and in the maintenance of neural physiological functions. In tumorcells, miR-128 expression is dysregulated through a variety of genetic and epigenetic events. Dysregulation: of miR-128 has profound effects on tumorigenesis and maintenance of tumor cells through alterations in cellular proliferation, differentiation, metabolism, and apoptosis. This article will review the latest advances in our understanding of miR-128, specifically in the context of clinical and fundamental cancer biology. Further characterization of miR-128 will likely identify its new roles in cancer biology. The use of miR-128 as a diagnostic and/or therapeutic tool may result in improvements in diagnosis, prognosis, and treatment of numerous cancers.
微小RNA(miRNA)是一类小的非编码RNA,是基因功能的关键调节因子。近年来,miRNA因其调节肿瘤细胞关键恶性特性的能力而越来越受到关注。微小RNA-128(miR-128)是一种在大脑中高度富集的miRNA,通常参与神经系统的发育以及神经生理功能的维持。在肿瘤细胞中,miR-128的表达通过多种遗传和表观遗传事件而失调。miR-128的失调通过细胞增殖、分化、代谢和凋亡的改变,对肿瘤发生和肿瘤细胞的维持产生深远影响。本文将综述我们对miR-128理解的最新进展,特别是在临床和基础癌症生物学背景下。对miR-128的进一步表征可能会确定其在癌症生物学中的新作用。将miR-128用作诊断和/或治疗工具可能会改善多种癌症的诊断、预后和治疗。